P20138 AF NFT

Myeloid cell surface antigen CD33

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeihfzmesswdyvhyy37m6nq6lhaiif6htxmavlgd6sfy2pmlkthospy/metadata.json
IPFS of structure file: 
bafybeidoy6uy6ab6w7prgiagklkafstv2ehk5rkfmv3ad3mrf5bd5sftuq/AF-P20138-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x02Ec5621A2d2D4f60b03875D3630DEF810B088E5
First NFT owner address (bech32): 
genesis1qtk9vgdz6t20vzcrsawnvvx7lqgtpz899q68yh
Current NFT ID #56201 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
56201
Accession (UniProt):
P20138
Name::
Myeloid cell surface antigen CD33
Experimental Method:
Predicted structure
Sequence source:
HOMO SAPIENS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P20138 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P20138|CD33_HUMAN Myeloid cell surface antigen CD33 OS=Homo sapiens OX=9606 GN=CD33 PE=1 SV=2 MPLLLLLPLLWAGALAMDPNFWLQVQESVTVQEGLCVLVPCTFFHPIPYYDKNSPVHGYWFREGAIISRDSPVATNKLDQEVQEETQGRFRLLGDPSRNNCSLSIVDARRRDNGSYFFRMERGSTKYSYKSPQLSVHVTDLTHRPKILIPGTLEPGHSKNLTCSVSWACEQGTPPIFSWLSAAPTSLGPRTTHSSVLIITPRPQDHGTNLTCQVKFAGAGVTTERTIQLNVTYVPQNPTTGIFPGDGSGKQETRAGVVHGAIGGAGVTALLALCLCLIFFIVKTHRRKAARTAVGRNDTHPTTGSASPKHQKKSKLHGPTETSSCSGAAPTVEMDEELHYASLNFHGMNPSKDTSTEYSEVRTQ